Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 24-889
Print  Notify Me  
Search documents in this case:
No. 24-889
 
Title: Hikma Pharmaceuticals USA Inc., et al., Petitioners
v.
Amarin Pharma, Inc., et al.
Docketed: February 19, 2025
Linked with: 24A652
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2023-1169)
   Decision Date: June 25, 2024
   Rehearing Denied: October 17, 2024
 
Proceedings and Orders
Dec 27 2024 Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice.
Main Document Proof of Service
Jan 03 2025 Application (24A652) granted by The Chief Justice extending the time to file until February 14, 2025.
Feb 14 2025 Petition for a writ of certiorari filed. (Response due March 21, 2025)
Petition Appendix Proof of Service Certificate of Word Count
Mar 04 2025 Motion to extend the time to file a response from March 21, 2025 to April 21, 2025, submitted to The Clerk.
Main Document
Mar 05 2025 Motion to extend the time to file a response is granted and the time is extended to and including April 21, 2025.
Mar 20 2025 Brief amici curiae of 30 Scholars of Law, Economics, and Medicine filed.
Main Document Proof of Service Certificate of Word Count
Mar 21 2025 Brief amicus curiae of Association for Accessible Medicines filed.
Main Document Certificate of Word Count Proof of Service
Apr 04 2025 Motion to extend the time to file a response from April 21, 2025 to May 15, 2025, submitted to The Clerk.
Main Document
Apr 07 2025 Motion to extend the time to file a response is granted and the time is further extended to and including May 15, 2025.
May 15 2025 Brief of respondents Amarin Pharma, Inc., et al. in opposition filed.
Main Document Certificate of Word Count Proof of Service
Jun 02 2025 Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed)
Main Document Proof of Service Certificate of Word Count
Jun 03 2025 DISTRIBUTED for Conference of 6/18/2025.
Jun 23 2025 The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Attorneys
Attorneys for Petitioners
Charles Bennett Klein
Counsel of Record
Winston & Strawn LLP
1901 L Street NW
Washington, DC 20036
cklein@winston.com
Ph: (202) 282-5000
Party name: Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals PLC


Attorneys for Respondents
Michael Robert Huston
Counsel of Record
Perkins Coie LLP
2525 E. Camelback Road
Suite 500
Phoenix, AZ 85016
mhuston@perkinscoie.com
Ph: 202-434-1630
Party name: Amarin Pharma, Inc., et al.


Other Attorneys
Charles Duan
Counsel of Record
American University Washington College of Law
4300 Nebraska Avenue NW
Washington, DC 20016
supremecourt.gov@cduan.com
Ph: (202) 274-4124
Party name: 30 Scholars of Law, Economics, and Medicine


Matthew S. Hellman
Counsel of Record
Jenner & Block LLP
1099 New York Ave., NW
Suite 900
Washington, DC 20001
MHELLMAN@JENNER.COM
Ph: 202-639-6000
Party name: Association for Accessible Medicines

 

Opinions
Filing & Rules
Oral Arguments
Case Documents
News Media
About
Visit
Contact Us | Site Map | Help | Fellows Program | Jobs | Links | Website Policies and Notices | Privacy Policy | USA.GOV
SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543